Stay updated on Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page’s footer revision version was updated from v3.5.2 to v3.5.3, indicating an interface/software release rather than a change to the underlying study details.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0, a site version/UI change that does not modify study details.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a minor metadata update with no visible changes to the study details.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded Primary peritoneal carcinoma and Fallopian tube cancer to the study's Conditions, and updated the page version from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-facing content changes were observed.SummaryDifference0.1%

Stay in the know with updates to Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.